Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
712
datasets available to search
ShareScore release 0.9.0
Dataset results
712 results for “mantle”
A Phase II Study Evaluating Glofitamab in Combination With Venetoclax Plus Zanubrutinib or Venetoclax Alone in Subjects With Untreated or Relapsed/Refractory High-risk Mantle-cell Lymphoma
ClinicalTrials.gov study NCT06558604. IPD Sharing: NO. Countries: 2. Publications: 0.
Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial
ClinicalTrials.gov study NCT06357676. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib, Rituximab, Venetoclax, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03710772. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Zanubrutinib in the Treatment of Recurrent Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05486013. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax and Eprenetapopt for the Treatment of Relapsed of Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04990778. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00038623. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Participants With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03647124. IPD Sharing: Not stated. Countries: 7. Publications: 0.
A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)
ClinicalTrials.gov study NCT07082686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Modified Immune Cells (CD19 CAR T Cells) and Acalabrutinib for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04484012. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)
ClinicalTrials.gov study NCT01504776. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03440567. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pomalidomide Plus Orelabrutinib and Zuberitamab in Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT07257510. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients
ClinicalTrials.gov study NCT05529069. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Pirtobrutinib, Rituximab (PR) in Previously Untreated Low and Intermediate Risk MCL (Mantle Cell Lymphoma) Patients
ClinicalTrials.gov study NCT06263491. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetically Risk-Stratified Venetoclax, Ibrutinib, Rituximab (± Navitoclax) in Relapsed/Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05864742. IPD Sharing: NO. Countries: 1. Publications: 0.
Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05214183. IPD Sharing: Not stated. Countries: 5. Publications: 0.
VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00063713. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT01078142. IPD Sharing: NO. Countries: 1. Publications: 0.
GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT06522386. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib Combined With Bendamustine and Rituximab in Newly Diagnosed Mantle Cell Lymphoma Patients Who Aged > 65 Years
ClinicalTrials.gov study NCT05406154. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.